Nexalin Technology NXL
NASDAQ NXL
$7.53 +3.25 (+75.93%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nexalin Technology (NXL) Debt Ratio (2021 - 2023)

Updated

Nexalin Technology's Debt Ratio came in at 0.11 for Q3 2023, up 88.4% from 0.06 a year earlier and up 16.7% from the prior quarter.

Analysis

Nexalin Technology (NXL) Debt Ratio (2021 - 2023) Analysis & Trends

For FY2022, Nexalin Technology's Debt Ratio was 0.07, down 90.9% from FY2021.

  • Going back by year, Debt Ratio was 0.74 in FY2021.
  • The Q3 2023 figure represents the highest quarterly Debt Ratio since Q4 2021.
  • Business Quant data shows NXL's Debt Ratio at 0.10 (Q2 2023), 0.08 (Q1 2023) and 0.07 (Q4 2022) in the three quarters before Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 0.38
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 0.30
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 0.29
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 0.30
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 0.31
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 0.28
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 0.04
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 0.33
10 Nexalin Technology 3.09 Mn -8.70 Mn 8,897.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 0.11
Jun 30, 2023 0.10
Mar 31, 2023 0.08
Dec 31, 2022 0.07
Sep 30, 2022 0.06
Dec 31, 2021 0.74
API Access

Nexalin Technology Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NXL&period=max&api_key=YOUR_API_KEY